Minerva Surgical, Inc. UTRS OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score

48/100

2/7 Pass

SharesGrow Intrinsic Value

Il y a eu 40 transactions d'initiés récentes enregistrées pour Minerva Surgical, Inc. (UTRS), dont 17 achats et 16 ventes. Le total des achats d'initiés s'élève à $6.04M et le total des ventes d'initiés à $14.76M.

Les initiés notables ayant une activité récente comprennent Cohen Daniel, Geiger Uri, Accelmed Partners Ii L.p.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — UTRS

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2023-03-01	Cohen Daniel	Director	Inconnu	-	-	-	122,189,638
2023-02-09	Geiger Uri	10 Percent Owner	Inconnu	-	-	-	122,189,638
2023-02-09	Accelmed Partners Ii L.p.	10 Percent Owner	Cession	-	-	-	122,189,638
2023-02-09	New Enterprise Associates 13 Lp	10 Percent Owner	Achat Informatif	24,437,927	$0.20	$5M	34,437,052
2023-01-02	Usen Todd	Chief Executive Officer	Inconnu	-	-	-	-
2022-07-19	Sung Derrick	Director	Attribution de RSU	86,956	$2.30	$200K	86,956
2022-07-19	Sung Derrick	Director	Inconnu	-	-	-	-
2022-06-10	Jaffe Ross A Md	Director	Attribution de RSU	49,792	$2.41	$120K	49,792
2022-06-10	Behbahani Ali	Director	Attribution de RSU	49,792	$2.41	$120K	58,279
2022-06-10	Renzi David	Director	Attribution de RSU	49,792	$2.41	$120K	49,792
2022-06-10	Anderson Jill	Director	Attribution de RSU	49,792	$2.41	$120K	49,792
2022-06-10	Coste Catherine	Director	Attribution de RSU	49,792	$2.41	$120K	129,579
2022-06-10	Hunt Niquette L.	Director	Attribution de RSU	49,792	$2.41	$120K	49,792
2022-05-02	Clapper David M	President and CEO	Attribution de RSU	229,732	-	-	323,232
2022-05-02	Jung Joel R	CFO	Attribution de RSU	60,198	-	-	220,730
2022-05-02	Filloux Dominique J.	COO	Attribution de RSU	60,198	-	-	266,289
2022-05-02	Skalnyi Evgueni V.	VP Medical Affairs	Attribution de RSU	49,755	-	-	244,725
2021-12-15	Clapper David M	President and CEO	Attribution de RSU	93,500	-	-	93,500
2021-12-15	Jung Joel R	CFO	Attribution de RSU	24,500	-	-	160,532
2021-12-15	Filloux Dominique J.	COO	Attribution de RSU	24,500	-	-	206,091
2021-12-15	Skalnyi Evgueni V.	VP Medical Affairs	Attribution de RSU	20,250	-	-	194,970
2021-12-13	Clapper David M	President and CEO	Achat Informatif	25,000	$4.94	$123.44K	642,660
2021-10-26	Jaffe Ross A Md	Director	Conversion (Vente)	279,942	$11.31	$3.17M	-
2021-10-26	Novo Holdings A/s	10 Percent Owner	Conversion (Vente)	-	-	-	-
2021-10-26	Jaffe Ross A Md	Director	Conversion (Vente)	24,760	-	-	-
2021-10-26	New Enterprise Associates 13 Lp	10 Percent Owner	Conversion (Vente)	596,183	-	-	-
2021-10-26	Behbahani Ali	Director	Conversion (Vente)	281	-	-	-
2021-10-26	Jaffe Ross A Md	Director	Conversion (Vente)	279,942	$11.31	$3.17M	-
2021-10-21	Jaffe Ross A Md	Director	Inconnu	-	-	-	-
2021-10-21	Jaffe Ross A Md	Director	Inconnu	-	-	-	-
2021-10-21	Clapper David M	President and CEO	Cession	382,732	$13.12	$5.02M	-
2021-10-21	Novo Holdings A/s	10 Percent Owner	Cession	592,648	-	-	-
2021-10-21	New Enterprise Associates 13 Lp	10 Percent Owner	Cession	-	-	-	-
2021-10-21	Behbahani Ali	Director	Cession	4,196	-	-	-
2021-10-21	Renzi David	Director	Cession	18,010	$13.12	$236.29K	-
2021-10-21	Anderson Jill	Director	Cession	60,783	$13.12	$797.47K	-
2021-10-21	Hunt Niquette L.	Director	Cession	60,783	$13.12	$797.47K	-
2021-10-21	Filloux Dominique J.	COO	Cession	48,130	$13.12	$631.47K	-
2021-10-21	Skalnyi Evgueni V.	VP Medical Affairs	Cession	71,782	$13.12	$941.78K	-
2021-10-21	Jaffe Ross A Md	Director	Inconnu	-	-	-	-

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration